In a 22-year-old woman with dysuria, mucopurulent cervical discharge, no cervical motion tenderness, and sterile pyuria, what is the most likely etiologic agent?

Most Likely Cause: Chlamydia trachomatis

In a 22-year-old woman presenting with dysuria, mucopurulent cervical discharge, and sterile pyuria (pyuria without bacteria on urinalysis), Chlamydia trachomatis is the most likely etiologic agent. 1

Clinical Reasoning

Cardinal Diagnostic Features Present

• Mucopurulent cervical discharge is the hallmark finding of cervicitis, and when a pathogen is identified, C. trachomatis is the most frequently isolated organism 1
• Sterile pyuria (pyuria without bacteriuria) is a classic presentation of chlamydial infection, historically termed "acute urethral syndrome" or "dysuria-pyuria syndrome," and strongly suggests chlamydial etiology rather than typical urinary tract infection 2
• Young age (22 years) is the single strongest risk factor; women under 25 years have markedly higher rates of chlamydial infection 1

Why Chlamydia Over Other Pathogens

Chlamydia vs. Gonorrhea:

• While N. gonorrhoeae is the second most common cause of mucopurulent cervicitis, C. trachomatis is isolated more frequently when a pathogen is identified 1
• Both can present identically, but the sterile pyuria pattern (3+ leukocyte esterase with pyuria but no bacteria) is particularly characteristic of chlamydial urethritis 2, 3
• In women with confirmed STIs and pyuria, 74% have sterile pyuria with negative urine cultures, a pattern strongly associated with chlamydial infection 3

Chlamydia vs. Trichomonas:

• Trichomonas vaginalis typically causes a frothy yellow-green discharge with intense vulvovaginal pruritus, which is not described in this case 1
• Trichomoniasis is less commonly associated with isolated cervicitis and sterile pyuria 1

Chlamydia vs. Herpes:

• Herpes simplex virus causes painful vesicular or ulcerative lesions, not mucopurulent discharge 1
• HSV cervicitis occurs primarily during primary infection and would present with visible ulcerations 1

Critical Epidemiologic Context

• Among young women (under 25) presenting with dysuria and diagnosed with UTI in emergency departments, 21% actually have chlamydia when tested 4
• In women presenting with dysuria, chlamydia is detected in 5-22% of cases, and is frequently missed when clinicians focus solely on UTI diagnosis 5, 4
• The absence of cervical motion tenderness rules out pelvic inflammatory disease but does not exclude cervicitis 1

Immediate Management Algorithm

Step 1: Initiate Empiric Therapy Immediately

Do not wait for NAAT results. This patient meets all criteria for immediate empiric treatment: age <25 years, sexually active, and clinical signs of cervicitis 1

• First-line regimen: Azithromycin 1 g orally single dose OR doxycycline 100 mg orally twice daily for 7 days 1

Step 2: Add Gonococcal Coverage

• Add ceftriaxone 500 mg IM if local gonorrhea prevalence exceeds 5% or if the patient is in a high-risk setting (young age, STD clinic, multiple partners) 1
• Given the clinical presentation is indistinguishable between chlamydia and gonorrhea, dual therapy is prudent in most emergency department settings 1

Step 3: Obtain Confirmatory Testing

• Nucleic acid amplification tests (NAATs) for C. trachomatis and N. gonorrhoeae on cervical or urine specimens (NAATs have >95% sensitivity vs. ~50% for microscopy) 1
• Wet-mount microscopy to assess for ≥10 WBC per high-power field and to detect Trichomonas (though wet-mount misses 30-50% of trichomoniasis cases) 1
• HIV and syphilis testing for every patient with a new STI diagnosis 1

Step 4: Partner Management

• All sexual partners within the preceding 60 days must be notified, examined, treated with the same regimen regardless of symptoms, and instructed to abstain from intercourse for 7 days after single-dose therapy or until completion of 7-day therapy 1

Common Pitfalls to Avoid

Pitfall #1: Treating as UTI Only

• Do not prescribe only UTI antibiotics (e.g., nitrofurantoin, trimethoprim-sulfamethoxazole) in young women with dysuria and sterile pyuria 4
• In one study, 66% of women with STIs and pyuria who were treated for presumed UTI had negative urine cultures and were inappropriately treated 3
• Among women with confirmed chlamydia who presented with dysuria, only 42% received appropriate chlamydial treatment when diagnosed with UTI 4

Pitfall #2: Over-Relying on Urinalysis Findings

• Pyuria is present in 37% of women with confirmed STIs, and 74% of these cases have sterile pyuria 3
• The presence of bacteria on urinalysis does NOT rule out concurrent STI; co-infection occurs 3
• Nitrite-positive urines in the setting of STIs are actually more likely (59%) to have negative urine cultures 3

Pitfall #3: Failing to Obtain Sexual History

• In emergency departments, only 17% of women with dysuria are asked about sexual history, yet 94% report recent sexual activity 4
• Always obtain sexual history in women under 30 presenting with dysuria, regardless of urinalysis findings 4

Pitfall #4: Assuming Absence of Discharge Rules Out STI

• Many women with chlamydial cervicitis are asymptomatic or have minimal symptoms 1, 2
• The asymptomatic carrier rate in young women is surprisingly high 2

Why Immediate Treatment Prevents Serious Sequelae

Prompt administration of appropriate antibiotics is directly linked to prevention of:

• Pelvic inflammatory disease 1
• Tubal infertility 1
• Ectopic pregnancy 1
• Chronic pelvic pain 1

Delaying therapy while awaiting test results increases the risk of progression to upper genital-tract infection, particularly in young women who may not return for follow-up 1